$2.04
0.73% today
Nasdaq, Jan 06, 06:15 pm CET
ISIN
US1570851014
Symbol
CERS

Cerus Corporation Stock price

$2.05
-0.02 0.97% 1M
+0.60 41.38% 6M
-0.01 0.49% YTD
+0.35 20.59% 1Y
-1.72 45.62% 3Y
-4.94 70.67% 5Y
-4.35 67.97% 10Y
-8.19 79.98% 20Y
Nasdaq, Closing price Mon, Jan 05 2026
+0.08 4.06%

Key metrics

Basic
Market capitalization
$393.8m
Enterprise Value
$400.2m
Net debt
$6.4m
Cash
$78.5m
Shares outstanding
192.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.7 | 1.7
EV/Sales
1.8 | 1.8
EV/FCF
2,353.9
P/B
6.4
Financial Health
Equity Ratio
27.9%
Return on Equity
-37.3%
ROCE
-7.5%
ROIC
-8.9%
Debt/Equity
1.4
Financials (TTM | estimate)
Revenue
$226.0m | $225.9m
EBITDA
$-8.1m | $10.2m
EBIT
$-9.5m | $-8.1m
Net Income
$-16.0m | $-15.7m
Free Cash Flow
$170.0k
Growth (TTM | estimate)
Revenue
14.2% | 12.2%
EBITDA
15.7% | 182.2%
EBIT
19.6% | 43.1%
Net Income
19.1% | 25.1%
Free Cash Flow
101.6%
Margin (TTM | estimate)
Gross
60.5%
EBITDA
-3.6% | 4.5%
EBIT
-4.2%
Net
-7.1% | -6.9%
Free Cash Flow
0.1%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
4.3%
Employees
622
Rev per Employee
$320.0k
Show more

Is Cerus Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.

Cerus Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Cerus Corporation forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Cerus Corporation forecast:

Buy
80%
Hold
20%

Financial data from Cerus Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
226 226
14% 14%
100%
- Direct Costs 89 89
14% 14%
40%
137 137
14% 14%
60%
- Selling and Administrative Expenses 79 79
8% 8%
35%
- Research and Development Expense 67 67
16% 16%
30%
-8.12 -8.12
16% 16%
-4%
- Depreciation and Amortization 1.37 1.37
37% 37%
1%
EBIT (Operating Income) EBIT -9.49 -9.49
20% 20%
-4%
Net Profit -16 -16
19% 19%
-7%

In millions USD.

Don't miss a Thing! We will send you all news about Cerus Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cerus Corporation Stock News

Neutral
Business Wire
27 days ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member blood centers produce approximately half of the U.S. platelet and cryoprecipitate supply. The agreement covers Cerus' entire INTERCEPT product line. Under this agr...
Positive
Seeking Alpha
about one month ago
CERS develops the Intercept Blood System for platelets, plasma, and IFC. These are valuable offerings for blood transfusions. CERS Intercept provides a pathogen-reduced transfusion product suite that directly address blood safety worldwide. IFC allows for room-temperature fibrinogen support that sharply reduces wasted product and turnaround times.
Neutral
Seeking Alpha
2 months ago
Cerus Corporation ( CERS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Timothy Lee William Greenman - President, CEO & Chairman Vivek Jayaraman - Chief Operating Officer Kevin Green - VP of Finance & CFO Conference Call Participants Junwoo Park - Cantor Fitzgerald & Co., Research Division John Wilkin - Craig-Hallum Capital Group LLC, Research Division Presentation Op...
More Cerus Corporation News

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Head office United States
CEO Obi Greenman
Employees 622
Founded 1991
Website www.cerus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today